Research Article
Volume 8 Issue 5 - 2021
The Prevalence of Fatty Liver Disease Assessed by Controlled Attenuation Parameter (CAP) by Fibroscan in Chronic Liver Disease
M Kadiri*, M Salihoun, M Acharki and N Kabbaj
Department of Gastroenterology “EFD-HGE”, Hospital Ibn Sina Rabat, Morocco
*Corresponding Author: M Kadiri, Department of Gastroenterology “EFD-HGE”, Hospital Ibn Sina Rabat, Morocco.
Received: March 23, 20211; Published: April 14, 2021




Abstract

Introduction and Aim: The CAP (Controlled Attenuation Parameter) function of FibroScan® is a new non-invasive diagnostic tool that allows the quantification of hepatic steatosis at the same time as elastometry. It calculates the attenuation of ultrasonic signals. The aims of our study are to determine the role of CAP values in predicting liver steatosis in patients with chronic liver diseases, and to determine factors associated with the presence of steatopathy.

Methods: Prospective, cross-sectional study, which was monocentric extending over 1 year. A CAP measurement by compact 530 fibroscan was performed using the M probe, or XL probe in the case of obesity, in all patients with chronic liver disease referred for liver elastometry, whatever its etiology and severity. Liver steatosis is graded based on the percentage of fat within the hepatocytes: grade 0: < 5%, grade 1: 5% -3 3%, grade 2: 34% - 66%, and grade 3: > 66%.

Results: Hepatic steatosis diagnosed by Fibroscan's CAP function is present in 40% of patients referred for evaluation of hepatic fibrosis for all causes of chronic liver disease. Severe hepatic steatosis is present in half of these patients. CAP values were significantly correlated with body mass index (p < 0.001), there was no correlation between CAP values and age, sex or etiology of hepatopathy nor with blood glucose, trigylceridemia, cholesterol level and liver enzymes.

Conclusion: The CAP is a promising imaging method for rapidly and non-invasively diagnosing liver steatosis.

Keywords: Controlled Attenuation Parameter; FibroScan; Liver Steatosis; Non-Invasively Diagnose

References

  1. Okanoue T., et al. “Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in Japan”. European Journal of Gastroenterology1 (2011): 153-162.
  2. Farrell GC and Larter CZ. “Nonalcoholic fatty liver disease: from steatosis to cirrhosis”. Hepatology 43 (2006): S99-S112.
  3. Tiniakos DG., et al. “Nonalcoholic fatty liver disease: pathology and pathogenesis”. Annual Review of Pathology 5 (2010): 145-171.
  4. Angulo P. “Nonalcoholic fatty liver disease”. The New England Journal of Medicine 346 (2002): 1221-131.
  5. Liou I and Kowdley KV. “Natural history of nonalcoholic steatohepatitis”. Journal of Clinical Gastroenterology 1 (2006): S11-16.
  6. Angulo P., et al. “Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis”. Hepatology 30 (1999): 1356-1362.
  7. Ratziu V., et al. “Sampling variability of liver biopsy in nonalcoholic fatty liver disease”. Gastroenterology 128 (2005): 1898-1906.
  8. Merriman RB., et al. “Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease”. Hepatology 44 (2006): 874-880.
  9. Castera L. “Non-invasive diagnosis of steatosis and fibrosis”. Diabetes and Metabolism Journal 34 (2008): 674-679.
  10. Mazhar SM., et al. “Noninvasive assessment of hepatic steatosis”. Clinical Gastroenterology and Hepatology 7 (2009): 135-140.
  11. Schwenzer NF., et al. “Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance”. Journal of Hepatology 51 (2009): 433-445.
  12. Charatcharoenwitthaya P and Lindor KD. “Role of radiologic modalities in the management of non-alcoholic steatohepatitis”. Clinical Liver Disease 11 (2007): 37-54.
  13. Sandrin L., et al. “Transient elastography: a new noninvasive method for assessment of hepatic fibrosis”. Ultrasound in Medicine and Biology 29 (2003): 1705-1713.
  14. De Ledinghen V., et al. “Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography”. Liver International 32 (2012): 911-918.
  15. Sasso M., et al. “Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes”. Ultrasound in Medicine and Biology 36 (2010): 1825-1835.
  16. Sandrin L., et al. “Shear elasticity probe for soft tissues with 1-D transient elastography”. IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control 49 (2002): 436-446.
  17. Kleiner DE., et al. “Design and validation of histological scoring system for nonalcoholic fatty liver disease”. Hepatology 41 (2005): 1313-1321.
  18. Sasso M., et al. “Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan®: validation in chronic hepatitis C”. The Journal of Viral Hepatitis 19 (2012): 244-253.
  19. Friedrich-Rust M., et al. “Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD”. European Journal of Radiology 81 (2012): 325-331.
  20. Xu XY., et al. “Performance of common imaging techniques vs serum biomarkers in assessing fibrosis in patients with chronic hepatitis B: A systematic review and meta-analysis”. World Journal of Clinical Cases 7 (2019): 2022-2037.
  21. Afdhal NH., et al. “Accuracy of fibroscan, compared with histology, in analysis of liver fibrosis in patients with hepatitis B or C: a United States multicenter study”. Clinical Gastroenterology and Hepatology 13 (2015): 772-779.
  22. Karlas T., et al. “Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis”. Journal of Hepatology 66 (2017): 1022-1030.
  23. HM Patton., et al. “The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients”. Journal of Hepatology3 (2004): 484-490.
  24. L Rubbia-Brandt., et al. “Steatosis affects chronic hepatitis C progression in a genotype specific way”. Gut3 (2004): 406 -412.
Citation: M Kadiri., et al. “The Prevalence of Fatty Liver Disease Assessed by Controlled Attenuation Parameter (CAP) by Fibroscan in Chronic Liver Disease”. EC Gastroenterology and Digestive System 8.5 (2021): 09-14.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


May Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the May issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for upcoming Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before May 24, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk